Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

被引：122

作者：

Wang, Rongfang ^{[1
]}

Song, Aihua ^{[1
]}

Levin, James ^{[1
]}

Dennis, Dawna ^{[1
]}

Zhang, Noelle J. ^{[1
]}

Yoshida, Hitoshi ^{[1
,2
]}

Koriazova, Lilia ^{[1
]}

Madura, Lydia ^{[1
]}

Shapiro, Laura ^{[1
]}

Matsumoto, Atsushi ^{[2
]}

Yoshida, Hideaki ^{[2
]}

Mikayama, Toshifumi ^{[2
]}

Kubo, Ralph T. ^{[1
,4
]}

Sarawar, Sally ^{[3
]}

Cheroutre, Hilde ^{[4
]}

Kato, Shinichiro ^{[1
,2
]}

机构：

[1] Kirin Pharma USA Inc, La Jolla, CA USA

[2] Kirin Pharma Co Ltd, Tokyo, Japan

[3] Torrey Pines Inst Mol Studies, San Diego, CA USA

[4] La Jolla Inst Allergy & Immunol, La Jolla, CA USA

来源：

ANTIVIRAL RESEARCH | 2008年 / 80卷 / 02期

关键词：

Influenza A; Matrix protein; Antibody; Virus infection; Protection;

D O I：

10.1016/j.antiviral.2008.06.002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Influenza is one of the most prevalent viral diseases in humans. For some high-risk human populations, including the infant, the elderly, and the immunocompromised, who may not benefit from active immunization, passive immunotherapy with antibodies reactive with all influenza A strains may be an alternative. In this study, we characterized several fully human monoclonal antibodies (MAb) reactive with M2e, which were generated from transchromosomic mice engineered to produce fully human antibodies following immunization with a consensus-sequence M2e peptide. The MAbs showed strong binding to M2e peptide and to virus infected MDCK cells. One MAb recognizing the highly conserved N-terminal portion of consensus M2e displayed high binding to the majority of M2e variants from natural viral isolates, including highly pathogenic avian strains, which were recently reported to infect humans. Passive immunotherapy with this MAb in mice resulted in significant reduction in virus replication in the lung and protection from lethal infection when administered either prophylactically or therapeutically. These results suggest the potential of the anti-M2e human MAb with broad binding spectrum as a universal passive immunotherapeutic agent to infection by influenza A virus. (C) 2008 Elsevier B.V. All rights reserved.

引用

收藏

页码：168 / 177

页数：10

相关论文

共 50 条

[11] Distinct domains of the influenza A virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production [J].

McCown, Matthew F. ;

Pekosz, Andrew .

JOURNAL OF VIROLOGY, 2006, 80 (16) :8178-8189

[12] A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes [J].

Clementi, Nicola ;

De Marco, Donata ;

Mancini, Nicasio ;

Solforosi, Laura ;

Moreno, Guisella J. ;

Gubareva, Larisa V. ;

Mishin, Vasiliy ;

Di Pietro, Andrea ;

Vicenzi, Elisa ;

Siccardi, Antonio G. ;

Clementi, Massimo ;

Burioni, Roberto .

PLOS ONE, 2011, 6 (12)

[13] Mutations in the Influenza A Virus M1 Protein Enhance Virus Budding To Complement Lethal Mutations in the M2 Cytoplasmic Tail [J].

Liu, Hsuan ;

Grantham, Michael L. ;

Pekosz, Andrew .

JOURNAL OF VIROLOGY, 2018, 92 (01)

[14] Expression in Plants of a Recombinant Protein Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin of Influenza Virus [J].

Blokhina, E. A. ;

Mardanova, E. S. ;

Tsybalova, L. M. ;

Ravin, N. V. .

APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2018, 54 (04) :404-409

[15] NOVEL ASSAY FOR THE INFLUENZA-VIRUS M2 CHANNEL ACTIVITY [J].

GIFFIN, K ;

RADER, RK ;

MARINO, MH ;

FORGEY, RW .

FEBS LETTERS, 1995, 357 (03) :269-274

[16] Genetic control of immune responses to influenza A matrix 2 protein (M2) [J].

Misplon, Julia A. ;

Lo, Chia-Yun ;

Gabbard, Jon D. ;

Tompkins, S. Mark ;

Epstein, Suzanne L. .

VACCINE, 2010, 28 (36) :5817-5827

[17] DNA compositional dynamics and codon usage patterns of M1 and M2 matrix protein genes in influenza A virus [J].

Deka, Himangshu ;

Nath, Durbba ;

Uddin, Arif ;

Chakraborty, Supriyo .

INFECTION GENETICS AND EVOLUTION, 2019, 67 :7-16

[18] Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody [J].

Mire, Chad E. ;

Geisbert, Joan B. ;

Borisevich, Viktoriya ;

Fenton, Karla A. ;

Agans, Krystle N. ;

Flyak, Andrew I. ;

Deer, Daniel J. ;

Steinkellner, Herta ;

Bohorov, Ognian ;

Bohorova, Natasha ;

Goodman, Charles ;

Hiatt, Andrew ;

Kim, Do H. ;

Pauly, Michael H. ;

Velasco, Jesus ;

Whaley, Kevin J. ;

Crowe, James E., Jr. ;

Zeitlin, Larry ;

Geisbert, Thomas W. .

SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (384)

[19] Mutations in the Membrane-Proximal Region of the Influenza A Virus M2 Protein Cytoplasmic Tail Have Modest Effects on Virus Replication [J].

Stewart, Shaun M. ;

Pekosz, Andrew .

JOURNAL OF VIROLOGY, 2011, 85 (23) :12179-12187

[20] Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody [J].

Geisbert, Thomas W. ;

Mire, Chad E. ;

Geisbert, Joan B. ;

Chan, Yee-Peng ;

Agans, Krystle N. ;

Feldmann, Friederike ;

Fenton, Karla A. ;

Zhu, Zhongyu ;

Dimitrov, Dimiter S. ;

Scott, Dana P. ;

Bossart, Katharine N. ;

Feldmann, Heinz ;

Broder, Christopher C. .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (242)

← 1 2 3 4 5 →